Skip to main content

Cruise beyond
heart failure and get back to doing the things you love

Do I Qualify?

Explore the world
beyond heart failure and get back to doing the things you love

Do I Qualify?

Swing beyond
heart failure and get back to doing the things you love

Do I Qualify?

Create memories
beyond heart failure and get back to doing the things you love

Do I Qualify?

barostim's baroreflex activation therapy device doodle barostim's baroreflex activation therapy device

A novel therapy option

If you suffer from the symptoms of heart failure, and the medications you have been prescribed are not enough to help you return to the activities you enjoy, Barostim may be the right therapeutic option for you.

How Barostim™ therapy works

Barostim is a simple and implantable device that works by stimulating baroreceptors – natural sensors in our body that tell the nervous system how to regulate heart, kidney and vascular function. These effects may reduce the heart’s workload and help it pump more efficiently, helping to relieve the symptoms of heart failure.

Patient outcomes

Barostim has been shown to safely improve symptoms of heart failure and your quality of life.

Patient walking icon

Exercise
capacity

Barostim patients were able to walk 60 meters farther in 6 minutes than patients on medications alone.

Barostim patients were able to walk 60 meters farther in 6 minutes than patients on medications alone.
Smiling face icon

Quality
of Life

Barostim patients had 3 times greater improvement in quality of life scores than patients on medications alone.

Barostim patients had 3 times greater improvement in quality of life scores than patients on medications alone.
Walking shoe icon

Functional
status

Two out of 3 patients with Barostim improved at least one whole NYHA class in 6 months.

Two out of 3 patients with Barostim improved at least one whole NYHA class in 6 months.
CVRx device icon

High
response rate

94% of patients had significant improvement in at least one of the three measures.

94% of patients had significant improvement in at least one of the three measures.

1. Zile MR, et al. J Am Coll Cardiol 2020; 76:1-13
2. Abraham WT, et al. Symptomatic endpoint responder rates to Barostim Therapy, ESC Abstract 2019

cvrx therapy

Turn your heart failure into heart success

Answer a few short questions to see if you may qualify for Barostim, then connect with a cardiologist in your area to schedule an evaluation.

Do I Qualify?
See if Barostim is an option for you arrow icon